Tenax Therapeutics, Inc. (TENX)

Tenax Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	111.45	94.85	9.79	2.12	5.58	6.25
Short-Term Investments	-	-	-	-	-	0.46
Cash & Short-Term Investments	111.45	94.85	9.79	2.12	5.58	6.71
Cash Growth	788.06%	868.66%	361.09%	-61.97%	-16.82%	24.32%
Prepaid Expenses	0.52	1.77	1.64	0.74	0.11	0.08
Other Current Assets	0.09	0.06	0.25	0.35	-	-
Total Current Assets	112.06	96.69	11.68	3.21	5.69	6.8
Property, Plant & Equipment	-	-	-	0.19	0.29	0.06
Other Long-Term Assets	-	-	0	0.01	0.01	0.01
Total Assets	112.06	96.69	11.69	3.4	5.99	6.87
Accounts Payable	1.84	3.16	2.07	0.45	0.86	0.76
Accrued Expenses	0.93	1.54	1.01	0.66	0.6	1.18
Short-Term Debt	-	-	0.5	0.62	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.12
Current Portion of Leases	-	-	-	0.12	0.11	0.06
Total Current Liabilities	2.77	4.69	3.59	1.85	1.56	2.12
Long-Term Debt	-	-	-	-	-	0.12
Long-Term Leases	-	-	-	0.06	0.18	-
Total Liabilities	2.77	4.69	3.59	1.91	1.75	2.24
Common Stock	-	-	-	0	0	0
Additional Paid-In Capital	434.55	406.85	305.35	291.03	282.74	250.64
Retained Earnings	-325.26	-314.86	-297.25	-289.54	-278.49	-246.02
Comprehensive Income & Other	-	-	-	-	-	-0
Total Common Equity	109.29	91.99	8.1	1.49	4.24	4.63
Shareholders' Equity	109.29	91.99	8.1	1.49	4.24	4.63
Total Liabilities & Equity	112.06	96.69	11.69	3.4	5.99	6.87
Total Debt	-	-	0.5	0.81	0.29	0.31
Net Cash (Debt)	111.45	94.85	9.29	1.32	5.29	6.41
Net Cash Growth	818.29%	920.89%	606.12%	-75.14%	-17.40%	22.56%
Net Cash Per Share	4.62	6.21	37.40	71.55	411.57	-
Filing Date Shares Outstanding	39.69	35.85	1.96	0.35	0.02	-
Total Common Shares Outstanding	39.51	35.3	0.3	0.03	0.02	-
Working Capital	109.29	91.99	8.1	1.36	4.13	4.68
Book Value Per Share	2.77	2.61	27.15	52.11	269.43	-
Tangible Book Value	109.29	91.99	8.1	1.49	4.24	4.63
Tangible Book Value Per Share	2.77	2.61	27.15	52.11	269.43	-

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q